"Neurological symptoms can range from headaches to tremors and movement disorders. Whether your condition is chronic or sudden and severe, we’ll ease your concerns by offering exceptional diagnosis and care. The Montana Neuroscience Institute at Providence St. Patrick Hospital is home to specialists who offer skilled treatment for common and rare brain, spine and nerve disorders. We offer all the services you need, from evaluation to neurosurgery or ongoing care for MS, Parkinson’s, dementia and many other neurological conditions. As a nationally certified Advanced Primary Stroke Center, our stroke experts are ready at any hour to offer fast, lifesaving care."

During the past decade, Montana Neuroscience Institute Foundation conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Montana Neuroscience Institute Foundation" #1 sponsor was "Pfizer" with 2 trials, followed by "Avanir Pharmaceuticals" with 1 trials sponsored, "Baxter Healthcare Corporation" with 1 trials sponsored, "Cephalon" with 1 trials sponsored and "Integra LifeSciences Corporation" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Montana Neuroscience Institute Foundation" #1 collaborator was "Apatech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Montana Neuroscience Institute Foundation" are "Pain" (2 trials), "Adhesions" (1 trials), "Cervical Myelopathy" (1 trials), "Chronic Noncancer Pain" (1 trials) and "Degenerative Disc Disease" (1 trials). Many other conditions were trialed in "Montana Neuroscience Institute Foundation" in a lesser frequency.

Most popular intervention types in "Montana Neuroscience Institute Foundation" are "Drug" (3 trials), "Device" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bone graft substitute, autograft or allograft" (1 trials), "DuraGen Plus Adhesion Barrier Matrix" (1 trials), "Neurodex" (1 trials), "OraVescent Fentanyl" (1 trials) and "Tanezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Montana Neuroscience Institute Foundation" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Montana Neuroscience Institute Foundation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Montana Neuroscience Institute Foundation, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Montana Neuroscience Institute Foundation, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".